Clinical Trials Sponsored by Renato Casarin

Total 800 results

Renato Casarin

Recruiting

Dimensional Changes in Alveolar Ridge Preservation

Alveolar Bone Loss

Brazil
Renato Correa Viana Casarin

Completed

Release of Osteogenic Markers in Immediately and Non-loaded Dental Implants

Jaw, Edentulous

Brazil
Servicio Canario de Salud
Fundación Canaria de Investigación y Salud

Withdrawn

Strategies for Improving Proton Pump Inhibitors (PPIs) Prescription Associated to Non-steroidal Anti-inflammatory Drugs (NSAIDs)

Adverse Events

Spain
University of Las Palmas de Gran Canaria
Servicio Canario de Salud

Completed

Intervention by Midwife to Address the Fear of Childbirth

Fear of Childbirth

Spain
Renata Medical

Active, not recruiting

Growth Trial: Study of the Renata Minima Stent

Coarctation of the Aorta | Pulmonary Artery Stenosis

United States
Renato Melaragno

Suspended

Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)

Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)
Renato Melaragno

Unknown

Phase II Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Chronic Myeloid Leukemia (CML) Philadelphia Chromosome-positive (Ph+)

Chronic Myeloid Leukemia (CML) With Philadelphia Chromosome-positive (Ph+)

Brazil
Renovo

Completed

Juvista in Scar Revision Surgery of Disfiguring Scars (Revise)

Cicatrix

Spain, France, Hungary, Italy, United Kingdom, United States, Denmark, Germany, Latvia, Poland
Renovo

Unknown

Prevascar in African Continental Group Scarring

Scarring

United Kingdom
Renovo

Unknown

Adaprev in Digital Flexor Tendon Repair

Tendon Injuries

United Kingdom
Renovo

Completed

Investigation Into the Scar Reduction Potential of Prevascar (Interleukin-10)

Cicatrix | Wound Healing

United Kingdom
Renovo

Completed

Investigation of the Efficacy of Zesteem in Accelerating Early Wound Healing

Cicatrix | Wound-healing

United Kingdom
Renovo

Completed

Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites

Cicatrix | Wound Healing

United Kingdom
Renovo

Completed

Safety and Efficacy Study of Avotermin (Juvista) in Female Subjects

Cicatrix | Wound Healing

United Kingdom
Renovo

Completed

Investigation Into the Safety of Intradermal Juvidex (M6P) Administered to Wounds of Healthy Subjects

Cicatrix | Re-epithelialisation

United Kingdom
Renovo

Completed

Investigation Into the Safety and Scar-improvement Efficacy of Intradermal Juvidex Dosed Once or Three Times

Cicatrix | Wound-healing

United Kingdom
Renovo

Completed

Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)

Cicatrix | Wound Healing

United Kingdom
Renovo

Completed

Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.

Cicatrix

United Kingdom
Renovo

Unknown

Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.

Cicatrix

United Kingdom
Renovo

Completed

Exploratory Study of the Efficacy and Safety of Juvista 250ng When Administered Following Excision of Ear Lobe Keloids

Keloid

United States
Renovo

Completed

Safety of Juvista When Administered Following Excision of Ear Lobe Keloids (RN1001-0093)

Keloid

United States
Renovo

Completed

Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista)

Cicatrix | Wound Healing | Re-epithelialization

United Kingdom
Renovo

Completed

Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid Scars

Keloid

United States
Renovo

Completed

Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites

Trauma | Burn | Varicose Ulcer

United Kingdom, Russian Federation, Germany, Latvia
Renovo

Completed

Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects

Cicatrix

United Kingdom
Renovo

Completed

Pharmacogenomic Analysis of Samples From Subjects in Study RN1004-0082

Wound

United Kingdom
Renovo

Completed

RN1001(Avotermin) in Scar Improvement Following Breast Augmentation

Cicatrix | Mammaplasty

United Kingdom
Renovo

Completed

Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy Males

Cicatrix

United Kingdom
Renovo

Completed

A Trial to Compare the Efficacy of Two Formulations of Avotermin Against Placebo (RN1006)

Scar Improvement

United Kingdom
Renovo

Withdrawn

Juvista in the Non-surgical Improvement of Existing Scars

Scars

United Kingdom
Renovo

Completed

Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects

Cicatrix | Wound Healing

United Kingdom
Renovo

Terminated

Juvista (Avotermin) in Breast Reduction Surgery Scars

Cicatrix | Mammaplasty

United Kingdom
Renovo

Completed

Juvidex (Mannose-6-Phosphate) in Accelerating the Healing of Split Thickness Skin Graft Donor Sites

Wound

United Kingdom
Renovo

Unknown

A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi Excision

Cicatrix | Nevus

United Kingdom
Renovo

Completed

Improvement in Scar Appearance Following Injection of Avotermin (Juvista) Into Skin Incisions Made in Healthy Men and Women

Cicatrix

United Kingdom
Renovo

Completed

Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin Incisions

Cicatrix

United Kingdom
Renatus, Antonio Renatus, Dent., M.Sc

Completed

Evaluation of a New Self-reported Tool for Periodontitis Screening

Periodontitis and Treatment Need
Asarina Pharma
Ergomed

Completed

A Study of Efficacy and Safety of Sepranolone (UC1010) in Patients With Premenstrual Dysphoric Disorder (PMDD)

Premenstrual Dysphoric Disorder

Sweden, Germany, Poland, United Kingdom
Asarina Pharma
Herlev Hospital

Completed

A Study to Explore the Effect of Sepranolone in Tourette Syndrome

Tourette Syndrome | Tourette Syndrome in Adolescence

Denmark
Rubato Life

Recruiting

Effects of an Algorithmically Enhanced Personalized Music-based Intervention in Patients With Dementia

Music

United States
Rubato Life

Recruiting

Evaluation of an Algorithmically Enhanced Personalized Music-based Intervention on Stress Reduction in Cancer Patients

Cancer | Stress

United States
Alessandro Haupenthal
Santa Catarina Federal University

Completed

Analysis of the Effects on Human Tissues After Application of Therapeutic Modalities.

Health | Young Adults | Humans

Brazil
Santa Catarina Federal University

Completed

Flaxseed Oil and Pomegranate Extract on Inflammation, Lipid Profile and Nutritional Status of Hemodialysis Patients

Inflammation | Chronic Kidney Diseases | Lipid Metabolism Disorders | Dialysis; Complications

Brazil
Asarina Pharma
Scandinavian CRO

Completed

A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine (APH204)

Menstrual Migraine

Finland, Sweden
Servicio Canario de Salud

Completed

Impact Evaluation of a Mobile Health App to Improve Self-control and Health Outcomes of Patients With Type 2 Diabetes Mellitus (T2DM): Pilot Study "NOVAME" (NOVAME)

Type 2 Diabetes Mellitus

Spain
Santa Catarina Federal University

Completed

Effects of Manipulative Therapy and Pain Education in Individuals With CLBP

Low Back Pain

Brazil
Santa Catarina Federal University

Completed

Intervention for Men Who Batter Women

Violence

Brazil
Santa Catarina Federal University

Completed

School-based Multicomponent Intervention on Physical Fitness Related to Health and Body Image

Body Image | Physical Fitness

Brazil
Amarin Pharma Inc.

Completed

Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL (MARINE)

Hypertriglyceridemia

United States, Netherlands, Russian Federation, Ukraine, Denmark, Finland, Germany, India, Italy, Mexico, South Africa
Amarin Pharma Inc.

Completed

Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL) (ANCHOR)

Hypertriglyceridemia

United States

3

Subscribe